Estudo randomizado | Bortezomibe em leucemia linfoblástica aguda e linfoma de células T recém-diagnosticados.

Children’s Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma – Journal of Clinical Oncology (link para o resumo – $ para o texto completo)

Comentário: New study finds bortezomib improves survival in children with newly diagnosed T-cell lymphoblastic lymphoma – Children’s Hospital of Philadelphia